Vanguard Global Advisers »

4d Molecular Therapeutics In shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $300k 32k 9.31

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding 4d Molecular Therapeutics In

Henderson Group
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
BVF
State Street Corporation
Armistice Capital
Federated Investors
Trails Edge Capital Partners
Adage Capital Partners GP
Geode Capital Management
Bank of America Corporation
Evergreen Quality Fund GP

View all funds holding 4d Molecular Therapeutics In